Oxford University Press

SHERPA: Yellow

People

  1. Weigelt
    Weigelt
  2. Selenica
    Selenica
  3. Pareja Zea
    Pareja Zea
  4. Chandarlapaty
    Chandarlapaty
  5. Riaz
    Riaz
  6. Mandelker
    Mandelker
  7. Norton
    Norton
  8. Ladanyi
    Ladanyi
  9. Robson
    Robson
  10. Gazzo
    Gazzo

Groups

  1. GSK Faculty (45)
  2. Department of Pathology and Laboratory Medicine (31)
  3. Department of Medicine (28)
  4. Solid Tumor Oncology Division (28)
  5. Breast Medicine Service (22)
  6. GDMT, Pathology and Laboratory Medicine (22)
  7. Gynecology Disease Management Team (22)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (19)
  9. Sloan Kettering Institute Postdocs (19)
  10. Human Oncology and Pathogenesis Program (16)
Search Within
  1. "Jorge Reis-Filho"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (11)
  3. Guidelines (4)
  4. Review (4)
  5. Editorial (1)
Groups
  1. GSK Faculty (45)
  2. Department of Pathology and Laboratory Medicine (31)
  3. Department of Medicine (28)
  4. Solid Tumor Oncology Division (28)
  5. Breast Medicine Service (22)
  6. GDMT, Pathology and Laboratory Medicine (22)

More Groups

People
  1. Jorge Reis-Filho (45)
  2. Britta Weigelt (21)
  3. Pier Selenica (16)
  4. Fresia Pareja Zea (11)
  5. Nadeem Riaz (9)
  6. Sarat Chandarlapaty (9)

More People

Years
  1. 2024 (1)
  2. 2023 (10)
  3. 2022 (8)
  4. 2021 (6)
  5. 2020 (3)
  6. 2019 (5)

More Years

Publications
  1. Annals of Oncology (27)
  2. JNCI: Journal of the National Cancer Institute (17)
  3. JNCI Cancer Spectrum (1)

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: A report from the ESMO Precision Medicine Working Group
    Guidelines

    Mosele, M. F.; Westphalen, C. B.; Stenzinger, A.; Barlesi, F.; Bayle, A.; Bièche, I.; Bonastre, J.; Castro, E.; Dienstmann, R.; Krämer, A.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Novel therapeutic opportunities in metaplastic breast cancer
    Meeting Abstract

    Pareja, F.; Gazzo, A.; Dopeso, H.; Brown, D.; Selenica, P.; Zhu, Y.; Blanco Heredia, J.; Gusain, L.; Pei, X.; Marra, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Alternative molecular mechanisms underpinning breast invasive lobular carcinoma identified by genomics-driven artificial intelligence model
    Meeting Abstract

    Pareja, F.; Dopeso, H.; Wang, Y. K.; Gazzo, A.; Brown, D.; Selenica, P.; Bernhard, J.; Sue, J.; Lee, M. C. H.; Godrich, R.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • APOBEC mutagenesis and macrophage infiltration in cancer
    Meeting Abstract

    Gazzo, A.; Marra, A.; Zhu, Y.; Gupta, A.; Selenica, P.; Pei, X.; Weigelt, B.; Pareja, F.; Riaz, N.; Reis, J. S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Pan-cancer assessment of the impact of intronic variants on cancer development and progression
    Meeting Abstract

    Safonov, A.; Mehine, M.; Ceyhan-Birsoy, O.; Brown, D.; Bandlamudi, C.; Forbes, A.; Gazzo, A.; Selenica, P.; Shen, R.; Khurana, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Detection of alternative lengthening of telomeres (ALT) across cancer types based on tumor-normal multigene panel sequencing
    Meeting Abstract

    Heredia, J. B.; Diplas, B. H.; El Nahhas, O. S. M.; Selenica, P.; Pareja, F.; Mandelker, D.; Weigelt, B.; Riaz, N.; Rosen, E.; Sfeir, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Combined patient specific tumor and HPV sequencing enables high sensitivity detection of ctDNA in HPV-associated oropharyngeal carcinoma patients
    Meeting Abstract

    Diplas, B. H.; Brown, D.; Pei, X.; Graybill, C.; Novaj, A.; Korn, W. M.; Daber, R.; Humm, J.; Shukla-Dave, A.; Schoder, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Prognostic and predictive impact of estrogen/progesterone receptor (ER/PR), and Ki-67 expression: An exploratory analysis from the monarchE trial in patients with high-risk, HR+, HER2-, early breast cancer (EBC)
    Meeting Abstract

    Goetz, M. P.; Turner, N.; Sasano, H.; Arteaga, C.; Chandarlapaty, S.; Loi, S.; Reis-Filho, J. S.; Kreipe, H.; Harbeck, N.; Fasching, P.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Regression-based deep-learning predicts breast cancer recurrence risk score from pathology slides
    Meeting Abstract

    El Nahhas, O. S. M.; Loeffler, C. M. L.; Marra, A.; Carrero, Z.; Pareja, F.; Wen, H.; Weigelt, B.; Selenica, P.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
    Review

    Tarantino, P.; Viale, G.; Press, M. F.; Hu, X.; Penault-Llorca, F.; Bardia, A.; Batistatou, A.; Burstein, H. J.; Carey, L. A.; Cortes, J.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save